VECT-HORUS
Marseille
About VECT-HORUS
VECT-HORUS is a biotechnology company that develops peptide-based vectors facilitating the drug delivery or imaging agents into the brain, organs, and tumors. The vectors target receptors involved in “Receptor-Mediated Transport” (RMT, a physiological system for the transport into cells of endogenous substances by combining drugs or imaging agents to its vectors, VECT-HORUS allows them to cross biological barriers that restrict access to their target, notably the blood-brain barrier (BBB). Founded in 2005 by Alexandre Tokay and Dr. Michel Khrestchatisky, the biotech company is based in Marseille, Marseille, Provence-Alpes-Cote d'Azur.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $21.3M
- Funding stage: Late Stage Venture
- Last round: Series D (Dec 2020)
- Website: vect-horus.com
- Phone: +33(0)4 91 69 87 81
Industries & Categories
Biopharma, Biotechnology, Health Care, Life Science
Social Profiles
Canonical: https://fsome.com/organization/vect-horus-132219 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.